Fresenius Kabi Compounding, Llc: Acyclovir Sodium, 200 Mg, 200mg Added To
Fresenius Kabi Compounding is recalling acyclovir sodium 200 mg intravenous injection bags nationwide because the company cannot guarantee they are sterile. The recalled product was distributed across all U.S. states and the District of Columbia. This is a Class I recall, the most serious type, indicating there is a reasonable possibility that use of the product could cause serious adverse health consequences or death.
- Recalling firm
- Fresenius Kabi Compounding, LLC
- Product
- acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
- Reason
- Lack of Assurance of Sterility
- Classification
- Class I
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-02-05
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/dcedc770-84da-4d7d-b606-7f67f4182a20